LMR Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-43,228
Closed -$153K 824
2025
Q1
$153K Buy
+43,228
New +$153K ﹤0.01% 661
2024
Q3
Sell
-113,300
Closed -$215K 621
2024
Q2
$215K Buy
+113,300
New +$215K ﹤0.01% 456
2024
Q1
Hold
0
737
2023
Q4
Hold
0
668